Acusphere's Oberg resigns as CEO

> Acusphere's co-founder and CEO Sherri Oberg will assume a new role as executive chair. She will retain the title of president, but has resigned as CEO. Release [1]

> Medivation has announced changes to its organizational structure. CFO Patrick Machado will transition to a new role, CBO. In addition, Medivation has recruited Karen Reeves as SVP, clinical development, and promoted Bryan Selby to become VP, biometrics, and Vandana Date as VP, intellectual property.

> Mario Portela has joined Amyris Biotechnologies as COO, strategic relationships & international executive chairman. In addition, Peter Boynton has joined the company as chief commercial officer. Release [2]| Release [3]

> Julie Gerberding, who headed the CDC while President George W. Bush was in office, is joining Merck as president of its $5 billion vaccines division. Story [4]

> Eli Lilly has announced that Derica Rice, the company's SVP and CFO for Lilly, has assumed expanded responsibilities and been promoted to EVP, global services and CFO. Story [5]

> Wolfgang Niedermaier, head of Acino's German operations, has decided to leave the company. Axel Müller, CEO of the Acino Group, will assume overall responsibility for the company's German operations in addition to his current function. Release [6]

> ImmunoGen has announced the appointment of Suzanne Cadden as VP of regulatory affairs & quality. Release [7]

> Seaside Therapeutics has appointed Tanya Lewis to the position of VP, regulatory affairs and quality assurance. Release [8]

> Protalix BioTherapeutics has announced the appointment of Sandra Lauterbach to VP, sales and commercial affairs. Release [9]

> Acceleron Pharma has expanded its management team with two newly created positions. The company has named Melissa Morandi as VP of quality and Kenneth Attie as VP of medical research. Release [10]

> Cell Medica has appointed Rainer Knaus as SVP, Mike Ramsay as head of U.S. operations Karen Hodgkin as head of clinical development, and Tina Crombie as head of business administration. Release [11]

> PharmAthene has named Jeffrey Runge to its board of directors. Release [12]

> Talecris Biotherapeutics has announced that Dean Jonathan Mitchell has been appointed to its board of directors. Mitchell's appointment brings the number of Talecris board members to 10. Release [13]

> AMAG Pharmaceuticals has announced that Lesley Russell, EVP and CMO of Cephalon, has been elected to its board of directors. Mark Skaletsky will resign from AMAG's board as of Dec. 31. Release [14]

> Carrie Cox has been elected to Celgene's board of directors. She has served as EVP and president of Schering-Plough's global pharmaceutical business. Release [15]

> Inovio Biomedical has appointed Iacob Mathiesen to its scientific advisory board. Release [16]

> DBV Technologies has named Robert Zeiger to its scientific advisory board. Release [17]

> Regis Technologies has added Nelson Zhao, Igor Likhotvorik, Sied Zegar and Dragan Ristic-all formerly of deCODE genetics, which recently filed for Chapter 11 protection in U.S. Bankruptcy Court.  Release [18]